Quote:
Originally Posted by JackIsBack
Actually.... exactly the opposite. If you simply have immunity from the mRna vaccination for COVID you just have antigen immunity based on just one protein (the spike protein)... if you had COVID and are immune, your immunity is based on multiple proteins in/on the virus and you also have Killer T cell immunity which has a far wider range of immunity because a variant virus can be recognized by your immune system and dealt with immediately, where the vaccine immunity may not. The virus is adapting (like the Delta variant) by changing it's spike protein, and that's why the vaccine's are failing against it, even though the virus is 99.9% identical to the original strain, the difference, the spike protein. People that have had some sort of COVID influenza or SARS (2003) previously are finding out that they are also immune from COVID even though those viruses are only 80% or so identical to COVID19 - having Killer T cells recognize some of the proteins on a virus are good enough for your immune system to react to that strain and start the immune response immediately. If you only recognize the spike protein, the protein that varies the most from strain to strain I might add... that's not long lasting immunity. Science.
|
This is also what Dr. Ryan Cole, a Mayo Clinic-trained pathologist who runs the largest independent laboratory in Idaho, recently said:
“A natural infection induces hundreds upon hundreds of antibodies against all proteins of the virus, including the envelope, the membrane, the nucleocapsid, and the spike,” said Dr. Cole, who has spent the past 16 months examining and culturing SARS-CoV-2 specimens. “Dozens upon dozens of these antibodies neutralize the virus when encountered again. Additionally, because of the immune system exposure to these numerous proteins (epitomes), our T cells mount a robust memory, as well. Our T cells are the ‘marines’ of the immune system and the first line of defense against pathogens. T cell memory to those infected with SARSCOV1 is at 17 years and running still.”
However, in vaccine-induced immunity, according to Cole, “we mount an antibody response to only the spike and its constituent proteins.” Cole explained how this produces much fewer neutralizing antibodies, and “as the virus preferentially mutates at the spike, these proteins are shaped differently and antibodies can no longer ‘lock and key’ bind to these new shapes.”